Actively Recruiting
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
Led by Shanghai Zhongshan Hospital · Updated on 2026-02-25
102
Participants Needed
1
Research Sites
185 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Participants will be given FMT through oral capsules or nasojejunal tube once a month. After three-time treatment, participants were followed up for three months. Participants complete specific scales to assess improvement in symptoms, emotion and quality of life. Besides, they report adverse effects and collect fecal samples at each visit.
CONDITIONS
Official Title
Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 to 70 years who meet the Rome IV criteria for irritable bowel syndrome diagnosis
- Patients who have not improved after trying at least three conventional IBS treatments
- Patients without red flag symptoms such as unexplained weight loss or blood in stool
You will not qualify if you...
- Pregnant, planning to become pregnant, or breastfeeding
- Having a psychiatric disorder or unable to cooperate with treatment and follow-up
- Having immunodeficiency or receiving immune-modulating medications
- Use of probiotics within the last 3 months or antibiotics within 1 month before the study
- History of abdominal surgery except appendectomy, gallbladder removal, cesarean section, or hysterectomy
- Having uncontrolled diabetes, high blood pressure, thyroid disease, or other systemic illnesses
- Having severe heart, brain, kidney, or lung diseases or cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
S
Shengdi Wu
CONTACT
L
Ling Dong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here